Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:37-45, doi:10.1016/j.jacc.2007.06.063
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afilalo, J.
Right arrow Articles by Eisenberg, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Afilalo, J.
Right arrow Articles by Eisenberg, M. J.
Related Collections
Right arrowRelated Articles

Statins for Secondary Prevention in Elderly Patients

A Hierarchical Bayesian Meta-Analysis

Jonathan Afilalo, MD*, Gustavo Duque, MD, PhD*,{dagger}, Russell Steele, PhD{ddagger}, J. Wouter Jukema, MD, PhD§, Anton J.M. de Craen, PhD|| and Mark J. Eisenberg, MD, MPH*,1,*

* Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada
{dagger} Division of Geriatrics and Bloomfield Center for Aging Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada
{ddagger} Department of Mathematics and Statistics, McGill University, Montreal, Canada
§ Division of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
|| Division of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, Netherlands
Divisions of Cardiology and Clinical Epidemiology, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada.


Figure 1
View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 QUOROM Flow Diagram

CHD = coronary heart disease; MI = myocardial infarction; QUOROM = Quality of Reporting of Meta-Analyses; RCT = randomized controlled trial.

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Bayesian Forest Plot for All-Cause Mortality

Statin therapy reduced the incidence of all-cause mortality by 22% over 5 years as compared to placebo. The posterior median estimate of the number need to treat was 28.

 

Figure 3
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Bayesian Forest Plot for Coronary Heart Disease Mortality

Statin therapy reduced the incidence of coronary heart disease mortality by 30% over 5 years as compared to placebo. The posterior median estimate of the number need to treat was 34.

 

Figure 4
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Bayesian Forest Plot for Nonfatal Myocardial Infarction

Statin therapy reduced the incidence of nonfatal myocardial infarction by 26% over 5 years as compared to placebo. The posterior median estimate of the number need to treat was 38.

 

Figure 5
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Bayesian Forest Plot for Revascularization

Statin therapy reduced the need for revascularization (percutaneous coronary intervention or aortocoronary bypass surgery) by 30% over 5 years as compared to placebo. The posterior median estimate of the number need to treat was 24.

 

Figure 6
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Bayesian Forest Plot for Stroke

Statin therapy reduced the incidence of stroke by 25% over 5 years as compared to placebo. The posterior median estimate of the number need to treat was 58.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement